← Back to Patent Explorer
US4994030A Expired / Lapsed US ⏱️ 0.0 years remaining

Reconstitution of human bone and tissue

Assignee: Osteotech Investment Corp
•
Filing: 1988-06-28
•
Granted: 1991-02-19
•
Expires: 2008-06-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A kit and process for reconstituting human bone and/or related tissue is disclosed. The kit comprises a pre-formulated sterilized reconstitution medium and double ended transfer needle.

Inventors

  • 👤 Frank P. Glowczewskie, Jr.
  • 👤 David A. Present
  • 👤 David W. Anderson
  • 👤 Patrick A. McBrayer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:58
CPC Classifications
A; A61; A61J; A61J1/00; A61J1/14; A61J1/20; A61J1/2089; A61F; A61F2/00; A61F2/02; A61F2/28; A61B; A61B50/00; A61B2050/005; A61B2050/0051; A61B2050/0056; A61B50/30; A61B50/31; A61B2050/311; A61J1/2003; A61J1/2006; A61J1/201; A61J1/2013

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 166 words
A kit for reconstituting human tissue selected from the group consisting of bone and musculoskeletal tissue, said kit comprising: (a) a sealed vessel containing a sterile preformulated reconstitution medium for said human tissue, said sealed vessel comprising an access site into the interior of said vessel; and (b) means for accessing the interior of said sealed vessel and for placing the interior of said vessel in open communication with the interior of a sealed vessel containing said human tissue necessitating reconstitution; wherein said pre-formulated reconstitution medium comprises a sterile aqueous solution including, in an amount suitable to preserve sterility of said human tissue during reconstitution and subsequent implant, a preservative selected from the group consisting of gentamicin sulfate, bacitracin, polymyxin B, neomycin and cefazolin sodium; and said means of accessing the interior of said sealed vessel comprises a hollow needle having two opposite pointed open ends and being separate from both said sealed vessel containing said reconstitution medium and said sealed vessel containing said human tissue.
Claim 2
Dependent Claim 166 words
A kit for reconstituting human tissue selected from the group consisting of bone and musculoskeletal tissue, said kit comprising: (a) a sealed vessel containing a sterile preformulated reconstitution medium for said human tissue, said sealed vessel comprising an access site into the interior of said vessel; and (b) means for accessing the interior of said sealed vessel and for placing the interior of said vessel in open communication with the interior of a sealed vessel containing said human tissue necessitating reconstitution; wherein said pre-formulated reconstitution medium comprises a sterile aqueous solution including, in an amount suitable to preserve sterility of said human tissue during reconstitution and subsequent implant, a preservative selected from the group consisting of gentamicin sulfate, bacitracin, polymyxin B, neomycin and cefazolin sodium; and said means of accessing the interior of said sealed vessel comprises a hollow needle having two opposite pointed open ends and being separate from both said sealed vessel containing said reconstitution medium and said sealed vessel containing said human tissue.
Claim 3
Dependent Claim 43 words
The kit according to claim 1 wherein said sealed vessel containing said sterile pre-formulated reconstitution medium comprises a vial having a mouth aseptically sealed with a snugly fitting stopper means, said stopper means providing said access site into the interior of said vessel.
Claim 4
Dependent Claim 16 words
The kit according to claim 2 wherein said snugly fitting stopper means is a rubber stopper.
Claim 5
Dependent Claim 145 words
A kit for reconstituting human tissue selected from the group consisting of bone and musculoskeletal tissue, said kit comprising: (a) a sealed vessel containing a sterile preformulated reconstitution medium for said human tissue, said sealed vessel comprising an access site into the interior of said vessel; (b) means for accessing the interior of said sealed vessel and for placing the interior of said vessel in open communication with the interior of a sealed vessel containing said human tissue necessitating reconstitution; wherein said pre-formulated reconstitution medium comprises a sterile aqueous solution of gentamicin sulfate having a concentration of from about 250 to about 1000 micrograms/ml.; and said means of accessing the interior of said sealed vessel comprises a hollow needle having two opposite pointed open ends and being separate from both said sealed vessel containing said reconstitution medium and said sealed vessel containing said human tissue.
Claim 6
Dependent Claim 145 words
A kit for reconstituting human tissue selected from the group consisting of bone and musculoskeletal tissue, said kit comprising: (a) a sealed vessel containing a sterile preformulated reconstitution medium for said human tissue, said sealed vessel comprising an access site into the interior of said vessel; (b) means for accessing the interior of said sealed vessel and for placing the interior of said vessel in open communication with the interior of a sealed vessel containing said human tissue necessitating reconstitution; wherein said pre-formulated reconstitution medium comprises a sterile aqueous solution of gentamicin sulfate having a concentration of from about 250 to about 1000 micrograms/ml.; and said means of accessing the interior of said sealed vessel comprises a hollow needle having two opposite pointed open ends and being separate from both said sealed vessel containing said reconstitution medium and said sealed vessel containing said human tissue.
Claim 7
Dependent Claim 21 words
The kit according to claim 4 wherein said sterile aqueous solution of gentamicin sulfate has a concentration of about 500 micrograms/ml.

References Cited (Backward Citations)

US3458397A Cited
US3542023A Cited
US4442655A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-02-18 1994-08-20 1995-02-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-02-18 1998-08-20 1999-02-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-02-18 2002-08-20 2003-02-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag